OTCGX
Price
$21.80
Change
+$0.36 (+1.68%)
Updated
Jan 3 closing price
PMAQX
Price
$44.48
Change
-$0.26 (-0.58%)
Updated
Jan 6 closing price
Ad is loading...

OTCGX vs PMAQX

Header iconOTCGX vs PMAQX Comparison
Open Charts OTCGX vs PMAQXBanner chart's image
MFS Mid Cap Growth R1
Price$21.80
Change+$0.36 (+1.68%)
VolumeN/A
CapitalizationN/A
Principal MidCap R6
Price$44.48
Change-$0.26 (-0.58%)
VolumeN/A
CapitalizationN/A
OTCGX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OTCGX vs. PMAQX commentary
Jan 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OTCGX is a Buy and PMAQX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 28.7B vs. OTCGX (15.2B). PMAQX pays higher dividends than OTCGX: PMAQX (0.10) vs OTCGX (0.00). OTCGX was incepted earlier than PMAQX: OTCGX (20 years) vs PMAQX (8 years). OTCGX is a more actively managed with annual turnover of: 30.00 vs. PMAQX (10.10). OTCGX (0) and PMAQX (0) have matching initial minimum investment requirements. PMAQX annual gain was more profitable for investors over the last year : 20.80 vs. OTCGX (8.95). PMAQX return over 5 years is better than : 44.50 vs. OTCGX (27.26).
OTCGXPMAQXOTCGX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years8 years-
Gain YTD1.8690.246758%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets15.2B28.7B53%
Annual Yield % from dividends0.000.10-
Returns for 1 year8.9520.8043%
Returns for 3 years-7.718.99-86%
Returns for 5 years27.2644.5061%
Returns for 10 years86.96N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DWTX2.610.10
+3.98%
Dogwood Therapeutics Inc
EDIT1.340.03
+2.29%
Editas Medicine
EB3.670.08
+2.23%
Eventbrite
EXEL33.970.03
+0.09%
Exelixis
VSAT9.08-0.45
-4.72%
ViaSat